Values First Advisors, Inc. Roivant Sciences Ltd. Transaction History

Values First Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.92 - $9.98 $38,620 - $55,698	-5,581 Reduced 45.89%	6,581 $48,000
Q4 2022 Jan 20, 2023	BUY	$3.36 - $7.99 $2,409 - $5,728	717 Added 6.26%	12,162 $0
Q3 2022 Dec 02, 2022	SELL	$0.51 - $4.84 $1,405 - $13,334	-2,755 Reduced 19.4%	11,445 $37,000
Q2 2022 Jul 20, 2022	BUY	$2.81 - $4.84 $39,902 - $68,728	14,200 New	14,200 $58,000

315

507M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.85B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.